Pear Therapeutics, Inc. filed a plan of liquidation with related disclosure statement in the US Bankruptcy Court on March 4, 2024. As per the plan filed, administrative claims, professional fee claims, priority tax claims, priority non-tax claims, other secured claims and WARN Act Class Settlement Claims of $0.99 million shall be paid in full in cash. General Unsecured Claims of $24.79 million shall be recovered 21%, i.e., in the amount of $5.21 million in cash.

No recovery shall be made towards subordinated claims and interests shall be cancelled. The plan shall be funded through cash in hand and sale of assets.